Sector Chart Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
12:06:42 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 2.545 USD | +1.80% |
|
-14.70% | -8.18% |
| 09-20 | Perspective Therapeutics, Inc.(NYSEAM:CATX) dropped from S&P Biotechnology Select Industry Index | CI |
| 09-18 | William Blair Initiates Perspective Therapeutics With Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 285M | - | ||||
| 49.06B | |||||
| 44.6B | |||||
| 43.24B | - | - | - | - | - |
| 41.73B | |||||
| 29.93B |
Select your edition
All financial news and data tailored to specific country editions
